Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis

OncoImmunology

Volumn 4, Issue 9, 2015, Pages 1-11

  Guillerey, Camille ^a,b   Chow, Melvyn T ^a   Miles, Kim ^a   Olver, Stuart ^a   Sceneay, Jaclyn ^a   Takeda, Kazuyoshi ^c   Möller, Andreas ^a,b   Smyth, Mark J ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Metastasis; Mouse; NK cell; TLR

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 15 RECEPTOR ALPHA; RECOMBINANT INTERLEUKIN 15; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; TUMOR GROWTH; TUMOR IMMUNITY; UPREGULATION;

EID: 84944457504     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1027468     Document Type: Article

References (51)

1. Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216; PMID:11861602; http://dx.doi.org/10.1146/annurev. immunol.20.083001.084359.
2. Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008; 60:805-12; PMID:18262679; http:// dx.doi.org/10.1016/j.addr.2007.11.005.
3. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164:5998-6004; http:// dx.doi.org/10.4049/jimmunol.164.11.5998.
4. Heinz S, Haehnel V, Karaghiosoff M, Schwarzfischer L, Muller M, Krause SW, Rehli M. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 2003; 278:21502-9; PMID:12672806; http://dx.doi.org/10.1074/jbc.M301476200.
5. Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ. APCindependent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004; 172:138-43; http://dx.doi.org/10.4049/ jimmunol. 172.1.138.
6. Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol 2007; 179:3472-9; http://dx.doi.org/10.4049/ jimmunol.179.6.3472.
7. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002; 293:1364-9; PMID:12054664; http://dx. doi.org/10.1016/S0006-291X(02)00380-7.
8. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68:7010-7; PMID:11083826; http://dx.doi.org/10.1128/IAI.68.12.7010-7017.2000.
9. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.org/ 10.1038/35099560.
10. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301:640-3; PMID:12855817; http://dx. doi.org/10.1126/science.1087262.
11. Yamashita M, Chattopadhyay S, Fensterl V, Zhang Y, Sen GC. A TRIF-independent branch of TLR3 signaling. J Immunol 2012; 188:2825-33; http://dx.doi.org/ 10.4049/jimmunol.1103220.
12. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A, Berlin AA, Lukacs NW. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 2006; 176:1937-42; http://dx. doi.org/10.4049/jimmunol.176.3.1937.
13. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 2004; 101:3516-21; PMID:14993594; http://dx.doi.org/10.1073/ pnas.0400525101.
14. Levy HB, Law LW, Rabson AS. Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A 1969; 62:357-61; PMID:4894326; http://dx.doi.org/10.1073/pnas.62.2.357.
15. Forte G, Rega A, Morello S, Luciano A, Arra C, Pinto A, Sorrentino R. Polyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancer. J Immunol 2012; 188:5357-64; http://dx.doi. org/10.4049/jimmunol.1103811.
16. Sharma S, Zhu L, Davoodi M, Harris-White M, Lee JM, St John M, Salgia R, Dubinett S. TLR3 agonists and proinflammatory antitumor activities. Expert Opin Ther Targets 2013; 17:481-3; PMID:23506058; http://dx.doi.org/10.1517/14728222.2013.781585.
17. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006; 176:4894-901; http://dx.doi. org/10.4049/jimmunol.176.8.4894.
18. Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, Ziparo E, Riccioli A. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism. Carcinogenesis 2008; 29:1334-42; PMID:18566014; http://dx. doi.org/10.1093/carcin/bgn149.
19. Shime H, MatsumotoM,Oshiumi H, Tanaka S, Nakane A, Iwakura Y,TaharaH, Inoue N, Seya T. Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci U S A 2012; 109:2066-71; PMID:22308357; http://dx.doi.org/ 10.1073/pnas.1113099109.
20. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res 2010; 70:2595-603; PMID:20233880; http://dx.doi.org/10.1158/0008-5472.CAN-09-1162.
21. Akazawa T, Ebihara T, Okuno M, Okuda Y, Shingai M, Tsujimura K, Takahashi T, Ikawa M, Okabe M, Inoue N, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci U S A 2007; 104:252-7; PMID:17190817; http://dx.doi.org/ 10.1073/pnas.0605978104.
22. McCartney S, Vermi W, Gilfillan S, Cella M, Murphy TL, Schreiber RD, Murphy KM, Colonna M. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med 2009; 206:2967-76; PMID:19995959; http://dx. doi.org/10.1084/jem.20091181.
23. Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T, Kumar H, Jang MH, Kawai T, et al. Poly I:C-induced activation of NK cells by CD8 αC dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol 2009; 183:2522-8; http://dx.doi. org/10.4049/jimmunol.0901500.
24. Chew V, Tow C, Huang C, Bard-Chapeau E, Copeland NG, Jenkins NA, Weber A, Lim KH, Toh HC, Heikenwalder M, et al. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients. J Natl Cancer Inst 2012; 104:1796-807; PMID:23197495; http://dx. doi.org/10.1093/jnci/djs436.
25. Hsu WM, Huang CC, Wu PY, Lee H, Huang MC, Tai MH, Chuang JH. Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma. Cancer Lett 2013; 336:338-46; PMID:23541683; http://dx.doi. org/10.1016/j.canlet.2013.03.024.
26. Fernandez-Garcia B, Eiro N, Gonzalez-Reyes S, Gonzalez L, Aguirre A, Gonzalez LO, Del Casar JM, Garcia-Muniz JL, Vizoso FJ. Clinical significance of tolllike receptor 3, 4, and 9 in gastric cancer. J Immunother 2014; 37:77-83; PMID:24509170; http://dx.doi. org/10.1097/CJI.0000000000000016.
27. Chan CJ, Andrews DM, Smyth MJ. Can NK cells be a therapeutic target in human cancer? Eur J Immunol 2008; 38:2964-8; PMID:18979512; http://dx.doi.org/ 10.1002/eji.200838764.
28. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-9; PMID:21212348; http://dx. doi.org/10.1126/science.1198687.
29. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005; 5:112-24; PMID:15688039; http://dx.doi.org/10.1038/nri1549.
30. Sivori S, Falco M, Carlomagno S, Romeo E,Moretta L, Moretta A. Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors. Int Immunol 2007; 19:1341-8; PMID:17962643; http://dx.doi.org/ 10.1093/intimm/dxm105.
31. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176:1517-24; http://dx.doi.org/10.4049/jimmunol.176.3.1517.
32. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, et al. Batf3 deficiency reveals a critical role for CD8αC dendritic cells in cytotoxic T cell immunity. Science 2008; 322:1097-100; PMID:19008445; http://dx.doi.org/10.1126/science. 1164206.
33. Ganal SC, Sanos SL, Kallfass C, Oberle K, Johner C, Kirschning C, Lienenklaus S, Weiss S, Staeheli P, Aichele P, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012; 37:171-86; PMID:22749822; http://dx.doi.org/ 10.1016/j.immuni.2012.05.020.
34. Kariko K, BucksteinM,NiH,Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005; 23:165-75; PMID:16111635; http://dx.doi.org/10.1016/j.immuni.2005.06.008.
35. Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, Merad M. Microbiotadependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014; 343:1249288; PMID:24625929; http://dx.doi.org/ 10.1126/science.1249288.
36. Oshiumi H,Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 2003; 4:161-7; PMID:12539043; http:// dx.doi.org/10.1038/ni886.
37. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class Ibearing tumor in vivo. Proc Natl Acad Sci U S A 2001; 98:11521-6; PMID:11562472; http://dx.doi.org/ 10.1073/pnas.201238598.
38. Smyth MJ, Crowe NY, Godfrey DI. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol 2001; 13:459-63; PMID:11282985; http://dx.doi.org/ 10.1093/intimm/13.4.459.
39. Smyth MJ, Taniguchi M, Street SE. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 2000; 165:2665-70; http://dx.doi.org/10.4049/jimmunol. 165.5.2665.
40. Jiang Q, Wei H, Tian Z. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I: C on the progression of murine melanoma. J Immunother 2008; 31:555-62; PMID:18528299; http://dx. doi.org/10.1097/CJI.0b013e31817d8e75.
41. Jonsson AH, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009; 101:27-79; PMID:19231592; http://dx.doi.org/ 10.1016/S0065-2776(08)01002-X.
42. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-17; PMID:17398124; http://dx.doi.org/ 10.1016/j.immuni.2007.03.006.
43. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C. Tolllike receptor expression in murine DC subsets: lack of TLR7 expression by CD8 αC DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003; 33:827-33; PMID:12672047; http://dx.doi.org/ 10.1002/eji.200323797.
44. Kasamatsu J, Azuma M, Oshiumi H, Morioka Y, Okabe M, Ebihara T, Matsumoto M, Seya T. INAM plays a critical role in IFN-gamma production by NK cells interacting with polyinosinic-polycytidylic acidstimulated accessory cells. J Immunol 2014; 193:5199-207; http://dx.doi.org/10.4049/jimmunol.1400924.
45. Chaix J, Tessmer MS, Hoebe K, Fuseri N, Ryffel B, Dalod M, Alexopoulou L, Beutler B, Brossay L, Vivier E, et al. Cutting edge: Priming of NK cells by IL-18. J Immunol 2008; 181:1627-31; http://dx.doi.org/ 10.4049/jimmunol.181.3.1627.
46. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279:12542-50; PMID:14729660; http://dx.doi.org/10.1074/jbc.M310175200.
47. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Hogaboam CM, Kunkel SL. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 2008; 205:2609-21; PMID:18838547; http://dx.doi.org/10.1084/jem. 20081370.
48. Yu P, Lubben W, Slomka H, Gebler J, Konert M, Cai C, Neubrandt L, Prazeres da Costa O, Paul S, Dehnert S, et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 2012; 37:867-79; PMID:23142781; http://dx.doi.org/ 10.1016/j.immuni.2012.07.018.
49. Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Moller A, Hill GR, Iwakura Y, Oft M, Smyth MJ. IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci U S A 2010; 107:8328-33; PMID:20404142; http://dx.doi.org/10.1073/pnas. 1003251107.
50. Takeda K, Nakayama M, Sakaki M, Hayakawa Y, Imawari M, Ogasawara K, Okumura K, Smyth MJ. IFNgamma production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. J Leukoc Biol 2011; 90:777-85; PMID:21712396; http://dx.doi.org/10.1189/jlb. 0411208.
51. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10; PMID:18425107; http://dx.doi.org/ 10.1038/ni1582.